Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Biomarin Pharmaceutical |
10.89 Bn |
8.67 Bn |
571.21 Mn |
-19.88% |
| Date | Value |
|---|
| Mar 31, 2026 |
-19.88% |
| Dec 31, 2025 |
-64.47% |
| Sep 30, 2025 |
-227.26% |
| Jun 30, 2025 |
116.78% |
| Mar 31, 2025 |
29.41% |
| Dec 31, 2024 |
78.18% |
| Sep 30, 2024 |
68.57% |
| Jun 30, 2024 |
122.54% |
| Mar 31, 2024 |
55.80% |
| Dec 31, 2023 |
34.12% |
| Sep 30, 2023 |
50.16% |
| Jun 30, 2023 |
75.79% |
| Mar 31, 2023 |
3.55% |
| Dec 31, 2022 |
-39.76% |
| Sep 30, 2022 |
-33.48% |
| Jun 30, 2022 |
54.45% |
| Mar 31, 2022 |
86.62% |
| Dec 31, 2021 |
-51.51% |
| Sep 30, 2021 |
-119.65% |
| Jun 30, 2021 |
51.54% |
